Researchers track Long-Term outcomes after brain AVM treatment
NCT ID NCT02879071
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 1000 adults who have had embolization for brain arteriovenous malformations (AVMs). The goal is to collect standardized long-term data, such as how well the AVM remains blocked over time. Currently, follow-up practices vary widely, so this research aims to improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondation Ophtalmologique Adolphe de Rothschild
RECRUITINGParis, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive HHT registry aims to unlock secrets of rare bleeding disorder
- Brain AVM drug trial pulled before it began
- Could a transplant drug shrink dangerous blood vessel tangles?
- Massive study aims to predict brain surgery success
- New study tracks pregnancy dangers in rare vascular conditions
- New hope for rare blood vessel disorders: everolimus trial launches